Christopher Seymour, MBA
October 17th, 2011
National Lipid Association Responds to Coverage of Its Statement on Biomarkers
Christopher Seymour, MBA
Editor’s Note: This contribution from Christopher R. Seymour, Executive Director of the National Lipid Association, is a response to Larry Husten’s October 13 blog post titled “National Lipid Association Expert Panel Has Many Deep Ties to Industry.” On behalf of the National Lipid Association (NLA), I want to address your inquiry regarding the paper titled “Clinical […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?